These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5434682)

  • 1. Accreditation program geared to broaden scope of pharmaceutical representatives.
    Can Hosp; 1970 Jan; 47(1):53. PubMed ID: 5434682
    [No Abstract]   [Full Text] [Related]  

  • 2. Accredited pharmaceutical manufacturers representatives.
    Bell W
    Can Med Assoc J; 1979 Jun; 120(11):1327. PubMed ID: 455177
    [No Abstract]   [Full Text] [Related]  

  • 3. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating pharmaceutical advertising: what will work?
    Shapiro MF
    CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmaceutical industry: a prescription.
    Woods D
    Can Med Assoc J; 1983 Oct; 129(7):675. PubMed ID: 6616369
    [No Abstract]   [Full Text] [Related]  

  • 7. Code of marketing practices. Voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada.
    Lexchin J
    Can Fam Physician; 1997 Nov; 43():1997. PubMed ID: 9386886
    [No Abstract]   [Full Text] [Related]  

  • 8. Health plan accreditation: NCQA, JCAHO, or both?
    Scanlon DP; Hendrix TJ
    Manag Care Q; 1998; 6(4):52-61. PubMed ID: 10185779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital policies on pharmaceutical sales representatives' activities.
    Oddis JA
    Resid Staff Physician; 1987 Sep; 33(10):8. PubMed ID: 10284382
    [No Abstract]   [Full Text] [Related]  

  • 10. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
    Desjardins JG
    CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dispensing drug samples from the emergency room; drug use evaluation requirements.
    Rich DS
    Hosp Pharm; 1994 Nov; 29(11):1042, 1044. PubMed ID: 10138579
    [No Abstract]   [Full Text] [Related]  

  • 13. On salvaging the pharmaceutical sciences in Canada?
    Jamali F; Pasutto FM
    J Pharm Pharm Sci; 1999; 2(2):36-7. PubMed ID: 10952766
    [No Abstract]   [Full Text] [Related]  

  • 14. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE
    CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract]   [Full Text] [Related]  

  • 15. "Disinformation" from pharmaceutical company representatives.
    Gordon M
    CMAJ; 1990 Sep; 143(5):370. PubMed ID: 2390749
    [No Abstract]   [Full Text] [Related]  

  • 16. Standards for pharmaceutical advertising in Canada.
    Chepesiuk R
    CMAJ; 2005 Aug; 173(3):238; author reply 238. PubMed ID: 16076811
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nations.
    Kelleher F
    Columbia J Law Soc Probl; 2004; 38(1):67-106. PubMed ID: 16755695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical education and the pharmaceutical industry.
    Goodman RL
    Perspect Biol Med; 2007; 50(1):32-9. PubMed ID: 17259674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Institution/investigator-initiated clinical trials in Canada.
    Sedgeworth J; Derewlany L
    Can J Clin Pharmacol; 2006; 13(2):e236-9. PubMed ID: 16873897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do pharmaceutical representatives misuse their drug samples?
    Tong KL; Lien CY
    Can Fam Physician; 1995 Aug; 41():1363-6. PubMed ID: 7580385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.